Abstract:Background Asthma is a global chronic respiratory disease with complex pathogenesis. While current therapies offer some relief, they often fall short in effectively managing symptoms and preventing exacerbations for numerous patients. Thus, understanding its mechanisms and discovering new drug targets remains a pressing need for better treatment. Methods Using the GEO dataset, we screened differentially expressed genes (DEGs) in asthma patients' blood. Employing Summary Data-based Mendelian Randomization (SMR) and Two-Sample Mendelian Randomization (TSMR), we pinpointed asthma causal genes, causal DNA methylation sites, and methylation sites affecting gene expression, cross validated with at least 2 large-scale GWAS from each source. We utilized colocalization for genetic associations, meta-analysis for data integration, two-step MR for methylation-gene-asthma mediation mechanism. Druggability was evaluated using Open Target, virtual screening, and docking. Results Among the 954 DEGs found in asthma patients' blood, increased expression of CEP95 (discovery, OR_SMR = 0.94, 95% CI: 0.91–0.97), RBM6 (discovery, OR_SMR = 0.97, 95% CI: 0.95–0.99), and ITPKB (discovery, OR_SMR = 0.82, 95% CI: 0.74–0.92) in the blood decreased the risk of asthma, higher levels of HOXB-AS1 (discovery, OR_SMR = 1.05, 95% CI: 1.03–1.07), ETS1 (discovery, OR_SMR = 1.62, 95% CI: 1.29–2.04), and JAK2 (discovery, OR_SMR = 1.13, 95% CI: 1.06–1.21) in the blood increased the risk of asthma. Additionally, a total of 8 methylation sites on ITPKB, ETS1, and JAK2 were identified to influence asthma. An increase in methylation at site cg16265553 raised the risk of asthma partially by suppressing ITPKB expression. Similarly, increased methylation at cg13661497 reduced the asthma risk totally by suppressing JAK2 expression. The impact of CEP95, HOXB-AS1, and RBM6 expressions on asthma was further confirmed in lung tissues. Except for HOXB-AS1, all the other genes were potential druggable targets. Conclusion Our study highlighted that specific gene expressions and methylation sites significantly influence asthma risk and revealed a potential methylation-to-gene-to-asthma mechanism. This provided pivotal evidence for future targeted functional studies and the development of preventive and treatment strategies.

Epigenetic signatures of asthma: a comprehensive study of DNA methylation and clinical markers

Integrative analysis identifies gene signatures mediating the effect of DNA methylation on asthma severity and lung function

Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission

SNPs Identified by GWAS Affect Asthma Risk Through DNA Methylation and Expression of Cis-Genes in Nasal (airway) Epithelium

Genetic contributions to epigenetic-defined endotypes of allergic phenotypes in children

m6A echoes with DNA methylation: Coordinated DNA methylation and gene expression data analysis identified critical m6A genes associated with asthma

Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes

The nasal methylome as a biomarker of asthma and airway inflammation in children

DNA methylation-mediated FGFR1 silencing enhances NF-κB signaling: implications for asthma pathogenesis

Methylated Genes in Sputum Among Older Smokers With Asthma

Current Smoking Affects Gene Expression and Methylation Patterns in Asthma Patient Nasal Epithelium

Shared DNA methylation signatures in childhood allergy: The MeDALL study

Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma.

A multi-omics Mendelian randomization identifies putatively causal genes and DNA methylation sites for asthma

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

Urinary Metabolomic Profiling Reveals Biological Pathways and Predictive Signatures Associated with Childhood Asthma

Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

Aberrant Methylation of Aging-Related Genes in Asthma

DNA methylation and gene expression profiles to identify childhood atopic asthma associated genes

CerS6 Gene Methylation in Peripheral Blood is Associated with Asthma and the Frequent Exacerbator Phenotype

An update on epigenetics and childhood respiratory diseases